findmyKOL
Clinical trialNCT03916081CompletedPhase 2Interventional

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

SponsorArcutis Biotherapeutics, Inc.Enrollment136Atopic Dermatitis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Arcutis Clinical Site 14

    Cobourg, Ontario, Canada

  • Arcutis Clinical Site 10

    Richmond Hill, Ontario, Canada

  • Arcutis Clinical Site 06

    Montreal, Quebec, Canada

United States
  • Arcutis Clinical Site 25

    Scottsdale, Arizona, United States

  • Arcutis Clinical Site 01

    San Diego, California, United States

  • Arcutis Clinical Site 19

    Hialeah, Florida, United States

  • Arcutis Clinical Site 18

    Miami, Florida, United States

  • Arcutis Clinical Site 17

    Sanford, Florida, United States

  • Arcutis Clinical Site 16

    Boise, Idaho, United States

  • Arcutis Clinical Site 12

    Indianapolis, Indiana, United States

  • Arcutis Clinical Site 13

    Plainfield, Indiana, United States

  • Arcutis Clinical Site 15

    Metairie, Louisiana, United States

  • Arcutis Clinical Site 03

    Fridley, Minnesota, United States

  • Arcutis Clinical Site 02

    High Point, North Carolina, United States

  • Arcutis Clinical Site 08

    Bexley, Ohio, United States

  • Arcutis Clinical Site 23

    Pittsburgh, Pennsylvania, United States

  • Arcutis Clinical Site 20

    Murfreesboro, Tennessee, United States

  • Arcutis Clinical Site 09

    College Station, Texas, United States

  • Arcutis Clinical Site 04

    San Antonio, Texas, United States

  • Arcutis Clinical Site 21

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2019
Primary completion
4 Nov 2019
Completion
4 Nov 2019
Last update posted
13 Feb 2023
Registered enrollment
136
Registry id
NCT03916081

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.